Biotechnology company and global drug delivery platform
innovator Lexaria Bioscience
(CSE: LXX) (OTCQX: LXRP)today announced the appointment of Brian Quigley to
its board of directors. Quigley most recently spent 16 years at Altria Group,
seven of which were spent as president and CEO for U.S. Smokeless Tobacco and
Nu-Mark, Altria’s innovation company, during the time that the existing Lexaria
and Altria business relationship was negotiated. Quigley is a 20-year Consumer
Packaged Goods veteran with a background of managing complex regulatory
environments including for novel and innovative nicotine products, and holds
additional deep experience with operations and marketing. “Lexaria continues to
build towards its role as one of the world’s leading reduced harm nicotine
delivery companies and we welcome Brian’s expertise,” Lexaria Chairman of the
Board Chris Bunka said in the news release. “His years of regulatory, product
launch, and Fortune-500 corporate experience will be an invaluable asset to Lexaria
as we expand our presence in reduced-harm nicotine products around the world.”
To view the full press release, visit http://ibn.fm/ZISzc
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. has developed and out-licenses its
disruptive delivery technology that promotes healthier ingestion methods, lower
overall dosing and higher effectiveness of lipophilic active molecules. Lexaria
has multiple patents pending in over 40 countries around the world and has
patents granted in the USA and in Australia for utilization of its
DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in
intestinal absorption rates; more rapid delivery to the bloodstream; and
important taste-masking benefits, for orally administered bioactive molecules
including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs
(NSAIDs), nicotine and other molecules. For more information, visit the
company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates
relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
